Biology Reference
In-Depth Information
3. The most important thing to remember while performing the
surgery is to maintain a visual on every action in order not to
cause additional damage.
4. Treatment is being given after the behavioral tests to minimize
influence from stress on behavioral tests due to handling the
animals during i.p. administration.
References
1. Baron R, Binder A, Wasner G (2010)
Neuropathic pain. Diagnosis, pathophysiologi-
cal mechanisms, and treatment. Lancet Neurol
9:807-819
2. Breivik H, Collett B, Ventafridda V, Cohen R,
Gallacher D (2006) Survey of chronic pain in
Europe: Prevalence, impact on daily life, and
treatment. Eur J Pain 10:287-333
3. Kuner R (2010) Central mechanisms of patho-
logical pain. Nat Med 16:1258-1266
4. Tanga FY, Raghavendra V, DeLeo JA (2007)
Quantitative real-time RT-PCR assessment of
spinal microglial and astrocytic activation
markers in a rat model of neuropathic pain.
Neurochem Int 45:397-407
5. Brines M, Ghezzi P, Keenan S, Agnello D, De
Lanorelle N, Cerami A (2000) Erythropoietin
crosses the blood-brain barrier to protect
against experimental brain injury. Proc Natl
Acad Sci U S A 97:10531-10536
6. Liao ZB, Zhi XG, Shi QH, He ZH (2008)
Recombinant human erythropoietin adminis-
tration protects cortical neurons from trau-
matic brain injury in rats. Eur J Neurol
15:140-149
7. Campana MW, Myers RR (2003) Exogenous
erythropoietin protects against dorsal root
ganglion apoptosis and pain following periph-
eral
11. Jia H, Feng X, Li W, Hu Y, Zeng Q, Liu J, Xu J
(2009) Recombinant human erythropoietin
attenuates spinal neuroimmune activation of neu-
ropathic pain in rats. Ann Clin Lab Sci 39:84-91
12. Jia H, Jin Y, Ji Q, Hu Y, Zhou Z, Xu J, Yang J
(2009) Effects of recombinant human eryth-
ropoietin on neuropathic pain and cerebral
expressions of cytokines and nuclear factor-
kappa B. Can J Aneasth 56:597-603
13. Sasaki N, Sekiguchi M, Kikuchi S, Konno S
(2011) Effects of asialo-erythropoietin on
pain-related behavior and expression of phos-
phorylated-P38 MAP kinase and tumor necro-
sis factor-alpha induced by application of
autologous nucleus pulposus on nerve root in
rat. Spine 36:E86-E94
14. Brines M, Patel NSA, Villa P, Brines C,
Mennini T, De Paola M, Erbayraktar Z,
Erbayraktar S, Sepodes B, Thiemermann C,
Ghezzi P, Yamin M, Hand CC, Xie QW,
Coleman T, Cerami A (2008) Nonerythro-
poietic, tissue-protective peptides derived from
the tertiary structure of erythropoietin. Proc
Natl Acad Sci U S A 105:10925-10930
15. Swartjes M, Morariu A, Niesters M, Brines M,
Cerami A, Aarts L, Dahan A (2011) ARA290,
a peptide derived from the tertiary structure of
erythropoietin, produces long-term relief of
neuropathic pain. An experimental study in
rats and
nerve
injury.
Eur
J
Neurosci
18:1497-1506
8. Sekiguchi Y, Kikuchi S, Myers RR, Campana
WM (2003) Erythropoietin inhibits spinal
neuronal apoptosis and pain following nerve
root crush. Spine 28:2577-2584
9. Keswani S, Buldanlioglu U, Fischer A, Reed
N, Polley M, Liang H, Zhou C, Jack C, Leitz
G, Hoke A (2004) A novel endogenous eryth-
ropoietin mediated pathway prevents axonal
degeneration. Ann Neurol 56:815-826
10. Campana WM, Li X, Shubayev VI, Angert M,
Cai K, Myers RR (2006) Erythropoietin
reduces Schwann cell TNF-a, Wallerian
degeneration and pain-related behaviors after
peripheral nerve injury. Eur J Neurosci
23:617-626
-common receptor knockout mice.
Anesthesiology 115:1084-1092
16. Sigtermans M, van Hilten JJ, Bauer M, Arbous
M, Marinus J, Sarton E, Dahan A (2009)
Ketamine produces effective and long-term
pain relief in patients with complex regional
pain syndrome type 1. Pain 145:304-311
17. Swartjes M, Morariu A, Niesters M, Aarts L,
Dahan A (2011) Nonselective and NR2B-
selective N-methyl-d-aspartic acid receptor
antagonists produce antinociception and long-
term relief of allodynia in acute and neuro-
pathic pain. Anesthesiology 115:165-174
18. Decosterd I, Woolf CJ (2000) Spared nerve
injury: an animal model of persistent periph-
eral neuropathic pain. Pain 87:149-158
β
Search WWH ::
Custom Search